Background-The purpose of this study was to identify determinants of 20-year change in left ventricular (LV) mass (LVM) and LV geometry in black and white young adults in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Methods and Results-We studied 2426 black and white men and women (54.7% white) aged 43 to 55 years with cardiovascular risk factor data and echocardiograms from CARDIA year 5 and 25 examinations. In regression models, year 25 LVM or relative wall thickness was the dependent variable and with year 5 echo values, age, sex, race, body mass index, change in body mass index, mean arterial blood pressure, change in mean blood pressure, heart rate, change in heart rate, tobacco use, presence of diabetes mellitus, alcohol use, and physical activity score as independent variables. LVM and relative wall thickness increased, whereas prevalence of normal geometry declined from 84.2% to 69.7%. Significant determinants of year 25 LVM/m 2.7 were year 5 LVM, year 5 and change in body mass index, year 5 and change in mean arterial pressure, year 5 and change in heart rate, baseline diabetes mellitus, and year 5 tobacco and alcohol use (overall r 2 =0.40). Significant determinants of year 25 relative LV wall thickness were year 5 value, black race, change in body mass index, year 5 and change in mean arterial pressure, starting smoking, and year 5 diabetes mellitus (overall r 2 =0.11).
L eft ventricular (LV) mass (LVM) and geometry are associated with adverse cardiovascular outcomes. While cross-sectional determinants of LVM and geometry are well understood, with obesity and elevated blood pressure being the major associations with higher LV size and wall thickness, the longitudinal determinants are less well understood, particularly in younger adults and for intervals of >5 years' duration. [1] [2] [3] [4] Although cross-sectional studies in diverse populations suggest LVM increases from young adulthood into middle age, there are few longitudinal studies documenting the rate of change, the influence of race and sex, and the importance of obesity in the evolution of LVM and geometry. Also missing from cross-sectional studies is the impact of chronic exposure to risk, for example, tobacco use or diabetes mellitus; these risk factors have shown small associations in cross-sectional studies, but the additive effects of chronic exposure are less well studied.
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In the Coronary Artery Risk Development in Young Adults (CARDIA) study, a longitudinal study of the evolution of cardiovascular risk, echocardiograms were performed in year 5, when participants were 23 to 35 years old, and repeated in year 25. 5 The purpose of this study was to assess the longitudinal determinants of LVM and geometry, paying particular attention to baseline risk and change in risk during the 20-year interval, including relationships to body size, blood pressure, tobacco use, markers of physical activity, and the development of diabetes mellitus. Of particular interest was the comparative impact on LVM and geometry of maintenance of cardiovascular health, defined as normal blood pressure, normal body mass index (BMI), nonsmoker, absence of diabetes mellitus, and absence of prior myocardial infarction versus the presence or worsening of risk over time.
Methods
The ongoing CARDIA study has been conducted at 4 field centers: Chicago, IL; Birmingham, AL; Oakland, CA; and Minneapolis, MN. At baseline, 5115 generally healthy whites and blacks were recruited from the general population, evenly divided by race, sex, and educational level (above and below high school graduation). The study was approved by the institutional review boards at the participating sites, and participants gave informed consent. Follow-up examinations conducted in the 1987-1988 period (year 2), 1990-1991 (year 5), 1992-1993 (year 7), 1995-1996 (year 10), and 2000-2001 (year 15) had retention rates of 90%, 86%, 81%, 79%, and 74% of the surviving cohort, respectively. At year 5, echocardiograms were performed on 4243 participants; in year 25, follow-up echocardiograms were done on 3474 participants, including 3145 with studies at both time points. Of 3145 participants who had echocardiograms at both examinations, 335 were missing measures for LV mass or relative wall thickness at year 25 and 73 were missing one or both of these measures at year 5, leaving 2737 participants in the sample. Finally, from these 2737 participants, 112 were missing data on other risk factors (eg, BMI, systolic blood pressure, physical activity, etc) and 199 had poor quality echocardiograms, leaving 2426 in the final analytic sample. Comparing those excluded with those included, the included cohort were more likely to be female and white, had lower blood pressure (3/2 mm Hg), BMI (1.5 kg/m 2 ), pulse (0.8 bpm), cigarette use, and alcohol intake and had a higher education level (0.7 years).
Echocardiograms
The protocol at year 5 has been previously published and followed existing American Society of Echocardiography guidelines for study acquisition and measurement. 5, 6 The protocol at year 25 followed the original year 5 protocol for data acquisition and measurement and was consistent with more current American Society of Echocardiography guidelines. 7 Measurements of LV dimensions (internal diameter in diastole, septal and posterior wall thicknesses in diastole) were acquired from 2-dimensional (2D)-guided M-mode echocardiograms obtained from optimized parasternal short-axis views. In both examinations, studies were transmitted to a core reading laboratory (video tape in year 5 to the University of California, Irvine, CA, digitally in year 25 at Johns Hopkins University). Quality control procedures included blind rereading and patient re-examination to allow assessment of intrareader variability, inter-reader variability, and intrapatient variability; coefficients of variability for LVM were <8% both at year 5 and at year 25. A subset of year 5 echo variables was reread at the Johns Hopkins reading center, which showed a bias of 21 g lower LV mass at year 5 with otherwise generally good agreement by Bland-Altman plots for LV mass and measurement components of the LV mass and relative wall thickness equations (data not shown). We think this difference is secondary to image degradation of the 20-year-old videotapes.
Risk Factor Assessment
All measurements were collected using standardized protocols across all field centers. Height and weight were measured in light clothing and BMI was calculated (weight [kilograms]/m 2 ). After 5 minutes' rest, blood pressure was measured 3 times by random-zero sphygmomanometer and the last 2 values averaged; resting heart rate was also measured. Mean arterial pressure was calculated as the sum of systolic pressure plus twice diastolic pressure all divided by 3. Diabetes mellitus status was ascertained at each examination based on a combination of history of medication use (every visit) history, fasting glucose ≥126 mg/dL (years 0, 7, 10, 15, 20, and 25), 2 hours from a glucose tolerance test (years 10, 20 and 25, glucose ≥200 mg/dL), or hemoglobin A 1c ≥6.5% (years 20 and 25). Alcohol use, tobacco use, antihypertensive medication use, and physical activity were assessed using questionnaires. A physical activity score was obtained from the CARDIA Physical Activity History, a modified version of the Minnesota Leisure Time Physical Activity Questionnaire. 8
Data Analysis
Individuals with echocardiograms at year 5 and 25 of fair or better quality were included. Descriptive statistics were calculated for all study variables, and comparisons between the cohorts at the 2 examination years were made by t test or χ 2 tests. LVM was calculated according to the American Society of Echocardiography recommendations. 7 LV relative wall thickness was calculated as 2 (LVPWd)/LVIDd, where LVPWd is the LV posterior wall diameter in diastole and LVIDd is the LV internal diameter in diastole. The cohort was stratified into 1 of 4 LV geometry groups at years 5 and 25: normal, concentric remodeling, LV eccentric hypertrophy, and LV hypertrophy (LVH) with concentric remodeling. LVH was defined as LVM >44 g/m 2.7 in women or >48 g/m 2.7 in men and concentric remodeling as LV relative wall thickness >0.42. 7 Longitudinal determinants of LVM were determined using linear regression by the general formula: LVM year 25 = year 5 echo variables (LVM or relative wall thickness)+demographic variables (age, sex, race)+baseline risk factor+change in risk factor+chronic risk exposure (antihypertensive use, smoking, diabetes mellitus). With regard to blood pressure, models that alternatively included systolic, diastolic, and mean blood pressure were run. These models were also run for both LVM and for LVM indexed to height. 2.7 A similar model was constructed for LV relative wall thickness. Sensitivity analyses were run to assess for possible bias created by some CARDIA participants being excluded from this cohort; results of these analyses were similar to those reported. LV geometry was assessed by creating a 2×2 table stratified, as defined above, for LVH and LV relative wall thickness (concentric remodeling) creating 4 groups: normal LVM and relative wall thickness, normal LVM with concentric remodeling, LV eccentric hypertrophy, and LVH with concentric remodeling. We also compared those who maintained normal LV geometry throughout the study with 3 groups: those who went from abnormal to normal, those who went from normal to abnormal, and those who stayed abnormal throughout with regard to change in risk status over 20 years.
Cardiovascular health was defined as having the following attributes at years 5 and 25: BMI of 18.5 to 25.0 kg/m 2 , blood pressure <130/85 mm Hg in the absence of pharmacological therapy, no tobacco use, absence of prior myocardial infarction, and absence of diabetes mellitus. Those with atrial fibrillation, myocardial infarction, and other cardiovascular events were also excluded from this group. The subgroup with these attributes was compared with the remaining cohort with regard to change in LVM, relative wall thickness, and prevalence of LV geometry classification using a repeated measures analysis with adjustment for age, sex, and race.
Results

Unadjusted Analyses of LVM, LVM Index, and LV Relative Wall Thickness
Descriptive statistics for the cohort at years 5 and 25 are presented in Table 1 . Overall, the cohort demonstrated increases in BMI (≈4 kg/m 2 ), blood pressure (≈12/6 mm Hg), diabetes mellitus prevalence (by 12.3%), and decreases in prevalence of tobacco use (by 9%) and self-reported physical activity (≈10%).
Descriptive statistics for LVM, LVM index, and LV relative wall thickness by race and sex are shown in Table 2 . Men had higher LVM than women. The largest changes occurred in blacks, in whom LVM increased by 14% in men and 22% in women; relative wall thickness increased by 0.01 in men and 0.02 in women. For whites, LVM increased ≈11% and there was no change in relative wall thickness.
The increases in LVM and relative wall thickness described above led to significant shifts in LV geometry over time. In the entire cohort, the prevalence of normal, concentric geometry, LVH with eccentric geometry, and LVH with concentric geometry at year 5 were 84.2%, 6.6%, 7.5%, and 1.7%, respectively, whereas at year 25 the prevalence were 69.7%, 7.6%, 15.3%, and 7.3%, respectively. In Figure 1 , classification of the cohort into 4 LV geometry groups (normal, concentric geometry, LVH with eccentric geometry, and LVH with concentric geometry) at years 5 and 25 is shown by race and sex. Black women changed most adversely, with a decline of 24% in normal geometry to a prevalence of only 53.5%.
Adjusted Analyses: Longitudinal Determinants of LV Mass and Relative Wall Thickness
Longitudinal determinants of LVM (raw and indexed to height 2.7 ) from linear regression models are shown in Table 3 .
Models were constructed to demonstrate the impact of year 5 risk, change in risk, and chronic exposures. Men had higher LVM than women. BMI, mean arterial pressure, and heart rate were significant determinants both at baseline and change, and the β-coefficients were similar for both baseline and change. Data on mean arterial pressure are shown as this variable had a larger effect than systolic or diastolic blood pressure. Chronic exposure variables were also significant. Ever smoking and the need for antihypertensive therapy were associated with increased mass. Interestingly, in the 6 patients no longer needing antihypertensive therapy, a lower LV mass was observed. Diabetes mellitus at year 5, but not newly diagnosed diabetes mellitus, was associated with a greater mass. To better understand the magnitude of these effects, the β-coefficients in Table 3 can be used to calculate the impact of a unit change in risk on LV mass. For example, for every 1 kg/m 2 increase in BMI, LV mass increases by an average of 2.5 g and tobacco use throughout the study increases LV mass by an average of 5 g. Longitudinal determinants of LV relative wall thickness from linear regression models are also shown in Table 3 . Black race and male sex were associated with increased relative wall thickness. Change in BMI and baseline and change in mean arterial pressure were positively associated as well. Starting smoking or antihypertensive medication was positively associated, with increased relative wall thickness.
Comparison of those who maintained cardiovascular health over 20 years, 15% of the cohort, with the remainder is shown in Figure 2 . Although LVM increased only slightly in those who remained healthy during the 20-year interval, there was a dramatic increase in LVM in the remaining participants, those without maintenance of cardiovascular health.
As a final analysis, we compared those who maintained normal geometry with 3 groups: those who went from abnormal to normal, those who went from normal to abnormal, and those who stayed abnormal throughout with regard to change in risk status for 20 years. Table 4 shows that increases in systolic blood pressure and BMI were highly associated with odds of worsening LV geometry as was persistent smoking. Starting antihypertensive medication during the study was associated with abnormal geometry at either year 5, year 25, or both examinations.
Discussion
This study has demonstrated an increase in LVM and lower prevalence of normal LV geometry for 20 years during the transition from young adulthood to middle age in black and white men and women. Increases in LVM and LV relative wall thickness over time were positively associated with BMI and blood pressure present at the first evaluation, when the cohort was 23 to 35 years of age, and change in these factors over a period of 20 years. Chronic risk exposure, in particular tobacco use, diabetes mellitus present at year 5, and the need for antihypertensive medication were associated with worse LVM and geometry. Resting heart rate was inversely associated with LVM, probably reflecting adaptation to improved fitness. Black women had the most adverse changes.
LVM and geometry are important independent determinants of cardiovascular morbidity and mortality. LVH is reportedly associated with a 2-to 3-fold increase in risk, and this may be particularly true for blacks. [9] [10] [11] Importantly, this study suggests that significant worsening of cardiac target organ injury occurs during the transition from young adulthood to middle age and this worsening may be driven by higher blood pressure, worsening obesity, tobacco use, and long-standing diabetes mellitus. Conversely, maintaining cardiovascular health leads to no significant worsening of LV target injury, and improving cardiovascular health will improve LVM and geometry.
Prior CARDIA publications have focused on LVM and geometry assessed from echocardiograms performed in year 5 and again in half the cohort in year 10. 5, 12 Risk associations in those studies are similar to those published herein. In longitudinal data from year 5 to year 10, there was very little change in LVM and geometry except in black women, in whom increased LVM was strongly associated with excess weight gain. 2 Novel to the current study is the observation that certain chronic exposures may have a particularly adverse association with LVM and geometry over time. These include an increasing impact of tobacco use compared with associations in year 5, an association with long-standing diabetes mellitus, and chronic increase or decrease depending on the continued need or lack of need for antihypertensive medication.
There are limited longitudinal echo data in younger individuals. 1, 2 The Bogalusa Heart Study and CARDIA have published 5-year follow-up data in biracial cohorts. In children and adolescents, interval growth, particularly onset of obesity and to a smaller extent blood pressure, determine change in LVM; in young adults in their 20s and early 30s, LVM changes with excess weight gain (most important) and blood pressure (also significant). Similar to this analysis, black women demonstrate the greatest change in LVM.
In older adults, the story seems more complex. 3, 4, 13 In the Framingham Heart Study, multiple echocardiograms were available for analysis during a 17-year period beginning at an average age comparable with the follow-up echocardiograms in the CARDIA cohort. Risk associations in these analyses (BMI, blood pressure and antihypertensive medication use, tobacco use, and diabetes mellitus) were very similar to the younger CARDIA cohort. An apparent protective effect of low-risk status was suggested; risk acquisition (particularly changes in blood pressure, blood pressure medication use, and diabetes mellitus) was associated with increased LVM. An independent effect of aging was also uncovered after adjustment for the expected associations with risk factors, with aging, LV cavity dimensions decreased slightly more rapidly than changes in wall thickness.
Longitudinal echo data also come from intervention trials. Losartan and other treatments for hypertension are reportedly associated with a reduction in LVM and improvement in cardiovascular outcomes (independent of blood pressure change). 14, 15 A bariatric surgery study has demonstrated that dramatic changes can occur in heart size with weight reduction. 16 It is interesting that our data suggest lowering blood pressure is associated with favorable effects on LVM and geometry but that the need for pharmacological therapy remains associated with higher LVM. This suggests the presence of a chronic effect of hypertension on the LV related to exposure to higher blood pressure before treatment.
For blacks, the most comparable data set to CARDIA is that of the Jackson Heart Study. 17 Mean age at examination of this cohort was 10 years greater than that in CARDIA, and the prevalence of abnormal LV geometry was also greater. Of interest, tracking the prevalence of LV geometry subtypes in blacks from the CARDIA year 5 examination (mean age, 29 years) to year 25 (mean age, 49 years) suggests a rate of increase in the prevalence of adverse LV geometry consistent with the high rates identified at a mean age of 59 years in the Jackson Heart Study. Because blacks are much more likely to develop heart failure at earlier ages, the demonstration of the rapid progression of adverse LV geometry associated with obesity, hypertension, cigarette use, and long-standing diabetes mellitus emphasizes the importance of early intervention for risk factor control. 18 An inverse association of heart rate with LVM was seen, independent of self-reported physical activity. This may reflect either greater physical fitness or compensation to normalize cardiac output at lower resting heart rates. 19 This effect, since it is associated with a health factor (fitness), suggests that the relationship of LVM with cardiovascular outcomes may not be linear: specifically, some increases in mass may be adaptive rather than pathological.
There are several limitations to this analysis. Echocardiograms were done 20 years apart on very different equipment; in particular, harmonic imaging was used in the year 25, but not the year 5, study and this technique increases LV mass measurements slightly. 11, 20 This effect may be compounded by the cubing of dimensions required in the LVM calculation. The definition of LVH, generally based on studies that did not use harmonic imaging techniques, may also require modification. 7 Although rigorous training and quality control procedures were followed, technicians performing the studies were trained in different eras and the reading centers were also different. Higher BMI and chronic lung disease worsen image quality in older individuals. Our prevalence estimates may be low as the excluded cohort had a slightly worse risk profile than those included in the analysis.
In summary, this study has demonstrated significant progression of LVM and concentric geometry over 20 years from young adulthood to middle age in a biracial and populationbased cohort initially recruited to assess the evolution of cardiovascular risk. This progression is related to both known risk factors (particularly BMI, blood pressure, and tobacco use) and chronic exposures (long-standing diabetes mellitus, need for antihypertensive medication, and tobacco use). Absence of an adverse cardiovascular risk factor profile was associated with minimal change in LV mass or geometry over time. These findings highlight the importance of initiating cardiovascular disease prevention early in the life course, initially with prevention of risk factor development and secondarily with risk factor control when necessary.
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